Meiragtx Holdings Plc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$12.23

+0.42 (+3.56%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +415.2% upside

Low Target $47.40

Average Target $63.01

High Target $83.78

Current Price $12.23

Current
$12.23

Target
$63.01

$47.40 $63.01 avg $83.78

Scenario Analysis

Bear Case

$47.40

287.6%

Low target

Base Case

$63.01

+415.2%

Avg target

Bull Case

$83.78

+585.0%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$11.85

3.2% from high

52-Week Low

$6.07

+101.5% from low

Target vs 52W High

$63.01

+431.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%